Polyvalent immunoglobulin use: Issues between good use, economic constraints and shortages over 25 years
Eur J Intern Med. 2024 Mar 25:S0953-6205(24)00124-9. doi: 10.1016/j.ejim.2024.03.019. Online ahead of print.NO ABSTRACTPMID:38531763 | DOI:10.1016/j.ejim.2024.03.019 (Source: European Journal of Internal Medicine)
Source: European Journal of Internal Medicine - March 26, 2024 Category: Internal Medicine Authors: Q Perrier V Tuloup C Chevallier-Brilloit P Bedouch S Chanoine Polyvalent immunoglobulin group Source Type: research

What is health-related quality of life? Long-term compliance of lipoprotein apheresis patients
Eur J Intern Med. 2024 Mar 23:S0953-6205(24)00131-6. doi: 10.1016/j.ejim.2024.03.023. Online ahead of print.NO ABSTRACTPMID:38521729 | DOI:10.1016/j.ejim.2024.03.023 (Source: European Journal of Internal Medicine)
Source: European Journal of Internal Medicine - March 23, 2024 Category: Internal Medicine Authors: Beatrice Dal Pino Carmen Corciulo Andrea Ripoli Federico Bigazzi Francesco Sbrana Source Type: research

Safety and compliance of long-term low-dose ondansetron in alcohol use disorder treatment
CONCLUSIONS: Low-dose AD04 has the potential to be a safe treatment option for subjects with AUD and ALD, indicating the need for an RCT for this specific cohort. Such a trial would pave the way for the design of a precision treatment for combined AUD with ALD.PMID:38521730 | DOI:10.1016/j.ejim.2024.03.017 (Source: European Journal of Internal Medicine)
Source: European Journal of Internal Medicine - March 23, 2024 Category: Internal Medicine Authors: Giovanni Addolorato Hannu Alho Paula Bresciani M De Andrade Otto Michael Lesch Lei Liu Bankole Johnson Source Type: research

What is health-related quality of life? Long-term compliance of lipoprotein apheresis patients
Eur J Intern Med. 2024 Mar 23:S0953-6205(24)00131-6. doi: 10.1016/j.ejim.2024.03.023. Online ahead of print.NO ABSTRACTPMID:38521729 | DOI:10.1016/j.ejim.2024.03.023 (Source: European Journal of Internal Medicine)
Source: European Journal of Internal Medicine - March 23, 2024 Category: Internal Medicine Authors: Beatrice Dal Pino Carmen Corciulo Andrea Ripoli Federico Bigazzi Francesco Sbrana Source Type: research

Safety and compliance of long-term low-dose ondansetron in alcohol use disorder treatment
CONCLUSIONS: Low-dose AD04 has the potential to be a safe treatment option for subjects with AUD and ALD, indicating the need for an RCT for this specific cohort. Such a trial would pave the way for the design of a precision treatment for combined AUD with ALD.PMID:38521730 | DOI:10.1016/j.ejim.2024.03.017 (Source: European Journal of Internal Medicine)
Source: European Journal of Internal Medicine - March 23, 2024 Category: Internal Medicine Authors: Giovanni Addolorato Hannu Alho Paula Bresciani M De Andrade Otto Michael Lesch Lei Liu Bankole Johnson Source Type: research

What is health-related quality of life? Long-term compliance of lipoprotein apheresis patients
Eur J Intern Med. 2024 Mar 23:S0953-6205(24)00131-6. doi: 10.1016/j.ejim.2024.03.023. Online ahead of print.NO ABSTRACTPMID:38521729 | DOI:10.1016/j.ejim.2024.03.023 (Source: European Journal of Internal Medicine)
Source: European Journal of Internal Medicine - March 23, 2024 Category: Internal Medicine Authors: Beatrice Dal Pino Carmen Corciulo Andrea Ripoli Federico Bigazzi Francesco Sbrana Source Type: research

Safety and compliance of long-term low-dose ondansetron in alcohol use disorder treatment
CONCLUSIONS: Low-dose AD04 has the potential to be a safe treatment option for subjects with AUD and ALD, indicating the need for an RCT for this specific cohort. Such a trial would pave the way for the design of a precision treatment for combined AUD with ALD.PMID:38521730 | DOI:10.1016/j.ejim.2024.03.017 (Source: European Journal of Internal Medicine)
Source: European Journal of Internal Medicine - March 23, 2024 Category: Internal Medicine Authors: Giovanni Addolorato Hannu Alho Paula Bresciani M De Andrade Otto Michael Lesch Lei Liu Bankole Johnson Source Type: research

A prediction model for differentiating recurrent Kawasaki disease from other febrile illnesses
Eur J Intern Med. 2024 Mar 21:S0953-6205(24)00128-6. doi: 10.1016/j.ejim.2024.03.020. Online ahead of print.NO ABSTRACTPMID:38519309 | DOI:10.1016/j.ejim.2024.03.020 (Source: European Journal of Internal Medicine)
Source: European Journal of Internal Medicine - March 22, 2024 Category: Internal Medicine Authors: Penghui Yang Jing Zhang Siqi Feng Qijian Yi Source Type: research

Subclinical atrial fibrillation patients, who are the best candidates for oral anticoagulant therapy?
Eur J Intern Med. 2024 Mar 20:S0953-6205(24)00119-5. doi: 10.1016/j.ejim.2024.03.015. Online ahead of print.NO ABSTRACTPMID:38514288 | DOI:10.1016/j.ejim.2024.03.015 (Source: European Journal of Internal Medicine)
Source: European Journal of Internal Medicine - March 21, 2024 Category: Internal Medicine Authors: Bi Huang David J Wright Gregory Y H Lip Source Type: research

Diagnosis traps for patients with acquired NLRP3 mutation
Eur J Intern Med. 2024 Mar 20:S0953-6205(24)00035-9. doi: 10.1016/j.ejim.2024.01.028. Online ahead of print.NO ABSTRACTPMID:38514289 | DOI:10.1016/j.ejim.2024.01.028 (Source: European Journal of Internal Medicine)
Source: European Journal of Internal Medicine - March 21, 2024 Category: Internal Medicine Authors: Margaux Cescato Laurence Cuisset Laurent Le Corre Mathieu P Rodero Sophie Georgin-Lavialle F-CAPS study group Source Type: research

Subclinical atrial fibrillation patients, who are the best candidates for oral anticoagulant therapy?
Eur J Intern Med. 2024 Mar 20:S0953-6205(24)00119-5. doi: 10.1016/j.ejim.2024.03.015. Online ahead of print.NO ABSTRACTPMID:38514288 | DOI:10.1016/j.ejim.2024.03.015 (Source: European Journal of Internal Medicine)
Source: European Journal of Internal Medicine - March 21, 2024 Category: Internal Medicine Authors: Bi Huang David J Wright Gregory Y H Lip Source Type: research

Diagnosis traps for patients with acquired NLRP3 mutation
Eur J Intern Med. 2024 Mar 20:S0953-6205(24)00035-9. doi: 10.1016/j.ejim.2024.01.028. Online ahead of print.NO ABSTRACTPMID:38514289 | DOI:10.1016/j.ejim.2024.01.028 (Source: European Journal of Internal Medicine)
Source: European Journal of Internal Medicine - March 21, 2024 Category: Internal Medicine Authors: Margaux Cescato Laurence Cuisset Laurent Le Corre Mathieu P Rodero Sophie Georgin-Lavialle F-CAPS study group Source Type: research

Visit-to-visit blood pressure variability is associated with intrinsic capacity decline: Results from the MAPT Study
CONCLUSIONS: Greater BPV is associated with IC decline over time. Our findings support BP instability as a presumable index of altered cardiovascular homeostatic mechanism, suggesting that BPV might be a clinical marker of aging and addressable risk factor for promoting healthy aging.PMID:38499456 | DOI:10.1016/j.ejim.2024.03.001 (Source: European Journal of Internal Medicine)
Source: European Journal of Internal Medicine - March 18, 2024 Category: Internal Medicine Authors: Leonardo Bencivenga Mathilde Strumia Yves Rolland Sophie Guyonnet Angelo Parini Philippe Cestac Sandrine Andrieu Philipe De Souto Barreto Laure Rouch MAPT/DSA group Source Type: research

Visit-to-visit blood pressure variability is associated with intrinsic capacity decline: Results from the MAPT Study
CONCLUSIONS: Greater BPV is associated with IC decline over time. Our findings support BP instability as a presumable index of altered cardiovascular homeostatic mechanism, suggesting that BPV might be a clinical marker of aging and addressable risk factor for promoting healthy aging.PMID:38499456 | DOI:10.1016/j.ejim.2024.03.001 (Source: European Journal of Internal Medicine)
Source: European Journal of Internal Medicine - March 18, 2024 Category: Internal Medicine Authors: Leonardo Bencivenga Mathilde Strumia Yves Rolland Sophie Guyonnet Angelo Parini Philippe Cestac Sandrine Andrieu Philipe De Souto Barreto Laure Rouch MAPT/DSA group Source Type: research

Visit-to-visit blood pressure variability is associated with intrinsic capacity decline: Results from the MAPT Study
CONCLUSIONS: Greater BPV is associated with IC decline over time. Our findings support BP instability as a presumable index of altered cardiovascular homeostatic mechanism, suggesting that BPV might be a clinical marker of aging and addressable risk factor for promoting healthy aging.PMID:38499456 | DOI:10.1016/j.ejim.2024.03.001 (Source: European Journal of Internal Medicine)
Source: European Journal of Internal Medicine - March 18, 2024 Category: Internal Medicine Authors: Leonardo Bencivenga Mathilde Strumia Yves Rolland Sophie Guyonnet Angelo Parini Philippe Cestac Sandrine Andrieu Philipe De Souto Barreto Laure Rouch MAPT/DSA group Source Type: research